<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02852317</url>
  </required_header>
  <id_info>
    <org_study_id>35RC14_8805</org_study_id>
    <nct_id>NCT02852317</nct_id>
  </id_info>
  <brief_title>Urinary Markers of Detrusor Overactivity in Spina Bifida Patients</brief_title>
  <acronym>BUHD-SPINA</acronym>
  <official_title>Urinary Markers of Detrusor Overactivity in Spina Bifida Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess diagnostic performance of urinary markers of detrusor
      overactivity (Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), adenosine
      triphosphate (ATP), Prostaglandine E2) in detected high pressure bladder un spina bifida
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 16, 2015</start_date>
  <completion_date type="Actual">July 17, 2017</completion_date>
  <primary_completion_date type="Actual">March 29, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of urinary markers will be evaluated by area under the curve (AUC)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">134</enrollment>
  <condition>Spina Bifida</condition>
  <condition>Multiple Sclerosis</condition>
  <condition>Spinal Cord Injury</condition>
  <condition>Overactive Bladder</condition>
  <arm_group>
    <arm_group_label>Spina bifida patient</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with multiple sclerosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with spinal cord injury</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with overactive bladder</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patient with an urodynamic examination scheduled
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Study arm:

          -  Spina bifida patient

          -  Seen consecutively in outpatient clinics

          -  Age &gt; 18 years-old

        Control arm:

          -  Patients with multiple sclerosis or spinal cord injury or overactive bladder

          -  Seen consecutively in urodynamics

          -  with lower urinary tract symptoms

          -  Age &gt; 18 years-old

        Exclusion Criteria:

          -  Positive urine culture

          -  History of urologic neoplasms

          -  History of interstitial cystitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre hospitalier universitaire de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>July 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>September 10, 2018</last_update_submitted>
  <last_update_submitted_qc>September 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Spinal Dysraphism</mesh_term>
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

